A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Methyprylon
Inotuzumab ozogamicin
The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Belinostat.
Methyprylon
Indacaterol
The serum concentration of Indacaterol can be increased when it is combined with Belinostat.
Methyprylon
Abemaciclib
The serum concentration of Abemaciclib can be increased when it is combined with Belinostat.
Methyprylon
Ceritinib
The serum concentration of Ceritinib can be increased when it is combined with Belinostat.
Methyprylon
Dabrafenib
The serum concentration of Dabrafenib can be increased when it is combined with Belinostat.
Methyprylon
Cobimetinib
The serum concentration of Cobimetinib can be increased when it is combined with Belinostat.
Methyprylon
Binimetinib
The serum concentration of Binimetinib can be increased when it is combined with Belinostat.
Methyprylon
Tedizolid phosphate
The risk or severity of myelosuppression can be increased when Belinostat is combined with Tedizolid phosphate.
Methyprylon
Cyclopenthiazide
The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclopenthiazide is combined with Belinostat.
Methyprylon
Mebutizide
The risk or severity of neutropenia and thrombocytopenia can be increased when Mebutizide is combined with Belinostat.
Methyprylon
Reviparin
The risk or severity of bleeding can be increased when Reviparin is combined with Belinostat.
Methyprylon
Troxerutin
The risk or severity of bleeding can be increased when Troxerutin is combined with Belinostat.
Methyprylon
(S)-Warfarin
The risk or severity of bleeding can be increased when (S)-Warfarin is combined with Belinostat.
Methyprylon
Fluindione
The risk or severity of bleeding can be increased when Fluindione is combined with Belinostat.
Methyprylon
Ximelagatran
The risk or severity of bleeding can be increased when Ximelagatran is combined with Belinostat.
Methyprylon
Coumarin
The risk or severity of bleeding can be increased when Coumarin is combined with Belinostat.
Methyprylon
Dabigatran
The risk or severity of bleeding can be increased when Dabigatran is combined with Belinostat.
Methyprylon
Edetate calcium disodium anhydrous
The risk or severity of bleeding can be increased when Edetate calcium disodium anhydrous is combined with Belinostat.
Methyprylon
Tocopherylquinone
The risk or severity of bleeding can be increased when Tocopherylquinone is combined with Belinostat.
Methyprylon
Saruplase
The risk or severity of bleeding can be increased when Saruplase is combined with Belinostat.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3